These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5107435)

  • 1. Incidence of thromboembolism after stopping anticoagulant therapy. Relationship to hemorrhage at the time of termination.
    Michaels L
    JAMA; 1971 Jan; 215(4):595-9. PubMed ID: 5107435
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticoagulant treatment of thromboses, a long term treatment].
    Flessinger JN
    Soins; 2006 Jun; (706):36-7. PubMed ID: 16821405
    [No Abstract]   [Full Text] [Related]  

  • 3. Bridging anticoagulation for patients on long-term vitamin-K-antagonists. A prospective 1 year registry of 311 episodes.
    Halbritter KM; Wawer A; Beyer J; Oettler W; Schellong SM
    J Thromb Haemost; 2005 Dec; 3(12):2823-5. PubMed ID: 16359528
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness and safety of vitamin K-antagonists in an anticoagulant clinic.
    Skov J; Ibrahim S; Jespersen J
    Thromb Res; 2016 Nov; 147():122-123. PubMed ID: 27736704
    [No Abstract]   [Full Text] [Related]  

  • 5. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.
    ; Bousser MG; Bouthier J; Büller HR; Cohen AT; Crijns H; Davidson BL; Halperin J; Hankey G; Levy S; Pengo V; Prandoni P; Prins MH; Tomkowski W; Torp-Pedersen C; Wyse DG
    Lancet; 2008 Jan; 371(9609):315-21. PubMed ID: 18294998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-intensity international normalized ratio (INR) oral anticoagulant therapy in Chinese patients with mechanical heart valve prostheses.
    Haibo Z; Jinzhong L; Yan L; Xu M
    Cell Biochem Biophys; 2012 Jan; 62(1):147-51. PubMed ID: 21892782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulant treatment in subjects over 70 years old].
    Fayard JM; Garrec L; Maurice P
    Coeur Med Interne; 1974; 13(2):353-8. PubMed ID: 4434703
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulant treatment of venous thromboembolism.
    Coon WW
    Surg Annu; 1972; 4():151-63. PubMed ID: 4668856
    [No Abstract]   [Full Text] [Related]  

  • 10. Is computer-assisted, long-term warfarin therapy safe and efficacious for patients with nonrheumatic atrial fibrillation?
    Perez-Gomez F
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):82-3. PubMed ID: 16265377
    [No Abstract]   [Full Text] [Related]  

  • 11. ["Education and follow-up Notebook for AVK treatment" legibility by hospitalized elderly].
    Bizard A; Bonnet-Zamponi D; Legrain S
    Presse Med; 2011 Sep; 40(9 Pt 1):886-8. PubMed ID: 21458211
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticoagulation of atrial fibrillation in older people: a clinical practice observational study.
    Abdelhafiz AH; Wheeldon NM
    J Am Geriatr Soc; 2006 Jan; 54(1):176-7. PubMed ID: 16420226
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulant therapy.
    Shapiro RM
    Am J Nurs; 1974 Mar; 74(3):439-43. PubMed ID: 4492902
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of anticoagulant therapy in myocardial infarctionl. Retrospective study].
    Leodolter I; Heil W; Frank H
    Munch Med Wochenschr; 1971 Sep; 113(36):1169-75. PubMed ID: 4998810
    [No Abstract]   [Full Text] [Related]  

  • 15. [Duration of antivitamin K therapy in venous thromboembolic disease].
    Ferrari E; Baudouy M; Morand P
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1891-4. PubMed ID: 8729371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oral versus intravenous phytonadione in patients with excessive anticoagulation.
    Key N
    Curr Hematol Rep; 2004 Sep; 3(5):315-6. PubMed ID: 15341696
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral anticoagulants.
    McGlasson DL
    Clin Lab Sci; 2004; 17(2):107-12. PubMed ID: 15168892
    [No Abstract]   [Full Text] [Related]  

  • 19. Risks and benefits of anticoagulant therapy.
    Levine MN
    Semin Thromb Hemost; 1986 Jan; 12(1):67-71. PubMed ID: 3961508
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal duration of oral anticoagulant therapy in venous thromboembolism.
    Schulman S
    Thromb Haemost; 1997 Jul; 78(1):693-8. PubMed ID: 9198241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.